Variant report
Variant | esv3322314 |
---|---|
Chromosome Location | chr5:124465453-124467051 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565215602 | chr5:124465510-124465511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559766392 | chr5:124465516-124465517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532601841 | chr5:124465521-124465522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527833646 | chr5:124465528-124465529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544417088 | chr5:124465546-124465547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562713103 | chr5:124465599-124465600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547600334 | chr5:124465649-124465650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527929306 | chr5:124465704-124465705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201937964 | chr5:124465729-124465730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138610529 | chr5:124465730-124465731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545189752 | chr5:124465733-124465734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144228285 | chr5:124465744-124465745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548224934 | chr5:124465781-124465782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573856593 | chr5:124465796-124465797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566382666 | chr5:124465874-124465875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544479615 | chr5:124465888-124465889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374343765 | chr5:124465894-124465895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181704958 | chr5:124465969-124465970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs70991662 | chr5:124465978-124465979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200460292 | chr5:124465979-124465980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113745363 | chr5:124465985-124465986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201736013 | chr5:124465988-124465989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13174120 | chr5:124465989-124465990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13156500 | chr5:124465991-124465992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs70991663 | chr5:124465999-124466000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370911294 | chr5:124466000-124466001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs60385052 | chr5:124466003-124466004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111603217 | chr5:124466006-124466007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11241787 | chr5:124466009-124466010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13174130 | chr5:124466011-124466012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374335146 | chr5:124466012-124466013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs13156507 | chr5:124466013-124466014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs59079949 | chr5:124466017-124466018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61492906 | chr5:124466023-124466024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs60789227 | chr5:124466027-124466028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs28674783 | chr5:124466034-124466035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57356039 | chr5:124466043-124466044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs60492631 | chr5:124466045-124466046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61153895 | chr5:124466051-124466052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs28494729 | chr5:124466053-124466054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs60055361 | chr5:124466059-124466060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs58608028 | chr5:124466062-124466063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs59751958 | chr5:124466067-124466068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs56157691 | chr5:124466070-124466071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs13174170 | chr5:124466079-124466080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13156544 | chr5:124466081-124466082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13174308 | chr5:124466087-124466088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs59178959 | chr5:124466089-124466090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs56132098 | chr5:124466093-124466094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs13156673 | chr5:124466095-124466096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 16397240 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:124456200-124470000 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr5:124456200-124470200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr5:124461400-124468200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr5:124464800-124465600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr5:124464800-124465600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr5:124464800-124465600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr5:124464800-124465600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr5:124464800-124465600 | Enhancers | HMEC | breast |
9 | chr5:124464800-124465800 | Enhancers | NHEK | skin |
10 | chr5:124465200-124465600 | Enhancers | HUVEC | blood vessel |
11 | chr5:124465200-124465600 | Enhancers | NHDF-Ad | bronchial |
12 | chr5:124465400-124470000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr5:124465400-124471000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
14 | chr5:124465600-124468600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr5:124465600-124470000 | Weak transcription | HUVEC | blood vessel |
16 | chr5:124465600-124470000 | Weak transcription | NHDF-Ad | bronchial |
17 | chr5:124466200-124468600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |